Rich countries getting new COVID vaccine before poorer ones

Mar 23, 2022, 10:02 PM | Updated: Mar 25, 2022, 8:34 pm
FILE - A worker moves boxes carrying Novavax's COVID-19 vaccine at SK Bioscience Co. in Andong, Sou...

FILE - A worker moves boxes carrying Novavax's COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9, 2022. Before the pandemic, Novavax was a small American company that had never brought any vaccine to market. Its shots have proven highly effective, but it is relying heavily on other companies to make them. (Kim Hyun-tae/Yonhap via AP, File)

(Kim Hyun-tae/Yonhap via AP, File)

NEW DELHI (AP) — The company behind a COVID-19 vaccine touted as a key tool for the developing world has sent tens of millions of doses to wealthy nations but provided none yet to the U.N.-backed effort to supply poorer countries, a sign that inequity persists in the global response to the pandemic.

A quarter-million doses from the company were supposed to be available to the vaccine-sharing initiative, called COVAX, by March. But the U.N. agency in charge of deliveries says the first shipments now likely won’t be made until April or May.

It wasn’t supposed to be this way. The company, Novavax, got $388 million from one of the organizations leading COVAX to fast-track the vaccine’s development and help make the shot available in poorer countries.

The investment guaranteed COVAX the “right of first refusal” to the first Novavax doses, but the deal applied only to factories in the Czech Republic, South Korea and Spain, said Bjorg Dystvold Nilsson, spokesman for COVAX co-founder CEPI.

There are other factories that aren’t part of the deal — and their shots are going elsewhere.

The Serum Institute of India, the world’s largest vaccine maker, has manufactured millions of Novavax doses. According to India’s Ministry of External Affairs and the institute, more than 28.9 million of those doses were sent to the Netherlands in January and February, while Australia received about 6 million doses. Indonesia also received about 9 million doses in December.

Thousands of other Novavax doses were also shipped from a Netherlands factory to other EU countries.

“Whatever the reason, a vaccine that was believed to be highly suitable for poor countries is now in large part going to rich countries,” said Zain Rizvi, a drug policy expert at the U.S. advocacy group Public Citizen. “It’s tragic that in year three of the pandemic, we still cannot get the resources, attention and political will to solve vaccine inequity.”

The delay is the latest setback for COVAX, which has been repeatedly hit by supply problems and has missed numerous targets to share doses.

Last year, WHO’s director-general Tedros Adhanom Ghebreyesus decried the chasm in vaccine supplies between rich and poor countries as a “catastrophic moral failure.”

Vaccine availability has been improving in poorer regions recently, but logistical problems persist.

According to data from Oxford University, only about 14% of people in low-income countries have received at least one dose of COVID-19 vaccine. More than 680 million doses of COVAX-provided vaccines remain unused or have expired, according to government data.

Even with vaccine supplies improving, some officials were eagerly awaiting the Novavax vaccine in particular because it is easier to transport and store than some other coronavirus shots. They also hoped it might be more enticing to people skeptical of the AstraZeneca vaccine, which suffered through a botched rollout in Europe.

Countries including Zimbabwe, the Central African Republic and Kiribati were among those in line to be offered Novavax doses by March from COVAX.

Before the pandemic, Novavax was a small American company that had never brought any vaccine to market. Its shots have proven highly effective, but it is relying heavily on other companies to make them.

The company, struggling to scale up production, also has delayed delivery to other countries, including some in the European Union. COVAX is supposed to receive more than 1 billion Novavax doses.

In a statement, the Gaithersburg, Maryland, company acknowledged that it had yet to share any shots with the vaccines alliance Gavi, which fronts the COVAX effort, but said it stands ready to do so.

“We continue to work with Gavi to reach our shared goal of ensuring global access to our protein-based vaccine where it is needed most,” Novavax said.

Gavi suggested part of the delay is that the Novavax vaccine wasn’t authorized by WHO until December. Gavi said it planned to allocate Novavax in the future and was “in close touch with the manufacturer and expects the supply to be available for delivery when countries need it.”

Health officials also worry that the urgency to vaccinate people everywhere against COVID-19 has disappeared — especially as many countries roll back precautions and the world’s attention is diverted.

“Rich countries have moved on from COVID and everyone is fixated on the war in Ukraine, but COVID-19 remains an acute crisis for most people in the world,” said Ritu Sharma, a vice-president at the charity CARE.

She said COVAX was still desperately short of vaccines and that based on the current pace of vaccination, the world was still “years and years” away from immunizing enough people to stop future COVID-19 waves.

Other experts said it was incumbent on public health agencies to ensure their investments into vaccines would benefit poor countries and to be more transparent about what went wrong.

“Whatever the explanation is, it’s unsatisfactory,” said Brook Baker, an access to medicines specialist at Northeastern University. “The bottom line is that there are still a lot of unvaccinated people in poor countries and once again, they are at the back of the line.”

___

Cheng reported from London. Follow AP’s coverage of the pandemic at https://apnews.com/hub/coronavirus-pandemic

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


              FILE - Employees pack boxes containing vials of Covishield, a version of the AstraZeneca vaccine, at the Serum Institute of India in Pune on Monday, Nov. 22, 2021. The Serum Institute of India, the world’s largest vaccine maker, has manufactured millions of Novavax doses, but none went to COVAX. According to India’s Ministry of External Affairs and the institute, more than 28.9 million Novavax doses were sent to the Netherlands in January and February, while Australia received about 6 million doses. Indonesia also received about 9 million doses in December. (AP Photo/Rafiq Maqbool, File)
            
              FILE - Kidney dishes with mounted syringes containing vaccines, from top, Novavax, Biontech and Moderna sit in a refrigerator in a vaccination center ready for vaccination in Prisdorf, Germany, Saturday, Feb. 26, 2022. Even with vaccine supplies improving, some officials were eagerly awaiting the Novavax vaccine in particular because it is easier to transport and store than some other coronavirus shots. (Georg Wendt/dpa via AP, File)
            
              FILE - A worker moves boxes carrying Novavax's COVID-19 vaccine at SK Bioscience Co. in Andong, South Korea, on Feb. 9, 2022. Before the pandemic, Novavax was a small American company that had never brought any vaccine to market. Its shots have proven highly effective, but it is relying heavily on other companies to make them. (Kim Hyun-tae/Yonhap via AP, File)

AP

FILE - Exterior view of the Peace Palace housing the U.N.'s International Court of Justice, or Worl...
Associated Press

Azerbaijan to UN court: Armenia must stop sowing land mines

THE HAGUE, Netherlands (AP) — Azerbaijan appealed Tuesday to the United Nations’ highest court to urgently order Armenia to stop the laying of land mines and booby traps on Azerbaijani territory and disclose the location of such explosives that already have been placed, in the latest legal battle focused on the mountainous Nagorno-Karabakh region. Azerbaijani […]
4 hours ago
FILE- A motorist rides past Adani Corporate House in Ahmedabad, India, Friday, Jan. 27, 2023. Asia'...
Associated Press

Richest Asian, Adani, targeted in $68B stock market rout

NEW DELHI (AP) — Asia’s richest man, Gautam Adani, saw his companies shed $68 billion in market value after short-selling firm Hindenburg Research accused him of “pulling the largest con in corporate history,” triggering a massive sell-off of Adani stocks. The report last week from U.S.-based Hindenburg attacked India’s second-largest conglomerate for alleged stock price […]
4 hours ago
FILE - A woman walks with purchases past a store in Berlin, Germany, Friday, April 1, 2022. Europe ...
Associated Press

Europe scrapes out economic growth by dodging gas disaster

FRANKFURT, Germany (AP) — Europe’s economy scraped out meager gains at the end of last year as galloping inflation fed by high energy prices and Russia’s invasion of Ukraine deterred people from spending in shops and restaurants. Economic output crept 0.1% higher in the last three months of 2022, European Union statistics agency Eurostat reported […]
4 hours ago
Associated Press

Thousands of care sector workers protest in Brussels

BRUSSELS (AP) — More than 10,000 people protested through central Brussels on Tuesday to demand better working conditions and more pay in the care sector which have been especially hard-hit during the COVID-19 pandemic. Trade union activists and workers are demanding that more people be hired in hospitals and care homes for older people, and […]
4 hours ago
(AP Photo/Susan Walsh)...
Associated Press

Biden to highlight grant for NYC rail tunnel under Hudson

WASHINGTON (AP) — New day, new tunnel. President Joe Biden is ready to showcase a $292 million mega grant that will be used to help build a new rail tunnel beneath the Hudson River between New York and New Jersey, part of a broader effort to draw a contrast between his economic vision and that […]
4 hours ago
FILE - A money changer counts Nigerian naira currency at a bureau de change, in Lagos Nigeria, Oct....
Associated Press

Nigeria sees cash shortage amid push for redesigned currency

ABUJA, Nigeria (AP) — Nigeria’s push to replace its paper money with newly designed currency notes has created a shortage of cash, leaving people unable to buy what they need and forcing businesses to close across the West African nation, experts and business groups said. The Central Bank of Nigeria says the redesigned denominations of […]
4 hours ago

Sponsored Articles

(Desert Institute for Spine Care photo)...
DESERT INSTITUTE FOR SPINE CARE

Why DISC is world renowned for back and neck pain treatments

Fifty percent of Americans and 90% of people at least 50 years old have some level of degenerative disc disease.
...
Quantum Fiber

How high-speed fiber internet can improve everyday life

Quantum Fiber supplies unlimited data with speeds up to 940 mbps, enough to share 4K videos with coworkers 20 times faster than a cable.
...
Children’s Cancer Network

Children’s Cancer Network celebrates cancer-fighting superheroes, raises funds during September’s Childhood Cancer Awareness Month

Jace Hyduchak was like most other kids in his kindergarten class: He loved to play basketball, dress up like his favorite superheroes and jump as high as his pint-sized body would take him on his backyard trampoline.
Rich countries getting new COVID vaccine before poorer ones